13D/13G Filings - LIFECORE BIOMEDICAL INC (LFCR)

Real time Form 13D and 13G transaction reports:

  • Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
  • Due to inconsistent filing format, it is highly recommended that you read the orignal filing form.
  • Shares have beem adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
Time period
Reported
DateTime
Transaction
Date
Type Company
Symbol
Filed By
Symbol
Shares Owned
% Owned
Shares Vs. Prev Report View
2024-11-12
5:55 pm
Purchase
2024-09-30 13G Lifecore Biomedical, Inc.
LFCR
David Capital Partners, LLC 1,655,000
5.360%
1,655,000increase
(New Position)
Filing
History
2024-07-02
4:54 pm
Purchase
2024-06-28 13D Lifecore Biomedical, Inc.
LFCR
WYNNEFIELD PARTNERS SMALL CAP VALUE LP I 5,007,666
16.000%
5,007,666increase
(New Position)
Filing
History
2024-01-11
4:40 pm
Purchase
2024-01-06 13D Lifecore Biomedical, Inc.
LFCR
22NW Fund LP 4,060,005
12.440%
4,060,005increase
(New Position)
Filing
History